There is no product in the shopping cart, buy it!
| Size | Qty | Add To Basket |
|---|---|---|
| 1 M cells/vial*2 |
| Description | GlycoErase™ PFKM knockout Jurkat cell line is a Jurkat T cell model without PFKM expression. PFKM encodes the muscle isoform of phosphofructokinase, catalyzing the rate-limiting glycolytic step. Mutations cause glycogen storage disease type VII (Tarui disease). This knockout model provides a tool to investigate glycolytic control, T cell metabolism, and inherited metabolic disorders in immune cells. |
| Product Type | KO Cell Lines |
| Species | Human |
| Cell Morphology | Suspension-growing |
| Passage Ratio | 1:3~1:5 |
| Cell Line | Jurkat cell line |
| Primary Disease | T-cell acute lymphoblastic leukemia (T-ALL) |
| Lineage | T Lymphocyte |
| Lineage Subtype | T-cell acute lymphoblastic leukemia (T-ALL) |
| Cell Viability | >90% |
| Sterility Test | The sterility test indicated an absence of microbial growth. |
| Identity Test | STR identification |
| Mycoplasma Test | Negative |
| Virus Test | Negative for HIV, HBV and HCV. |
| Genetic Stability Testing | We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements. |
| Validation | PCR, Sanger Sequencing |
| Culture Medium | FBS & Penicillin/Streptomycin & RPMI |
| Application | Functional assay |
| Size | 1 M cells/vial*2 |
| Product Format | Frozen |
| Shipping | Dry ice |
| Availability Status | Made to order |
| Handling Notes | Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to. |
| Product Disclaimer | This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous. |
| Target | PFKM |
| Full Name | Phosphofructokinase, Muscle |
| Alternative Name | GSD7; PFK1; PFKA; PFKX; PFK-1; PFK-A; ATP-PFK; PPP1R122 |
| Location | 12q13.11 |
| Gene ID | 5213 |
| Summary | Three phosphofructokinase isozymes exist in humans: muscle, liver and platelet. These isozymes function as subunits of the mammalian tetramer phosphofructokinase, which catalyzes the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate. Tetramer composition varies depending on tissue type. This gene encodes the muscle-type isozyme. Mutations in this gene have been associated with glycogen storage disease type VII, also known as Tarui disease. Alternatively spliced transcript variants have been described. |